MGI Aloxi Distribution Doubles In January; Firm Sees ’04 Sales Of $80-$90 Mil.
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Demand for MGI’s antiemetic Aloxi doubled in January from the prior month, the firm reported Feb. 11.